Simultaneous detection of ten psychedelic phenethylamines in urine by gas chromatography-mass spectrometry

Journal of Analytical Toxicology

Volumn 35, Issue 7, 2011, Pages 459-469

  Kerrigan, Sarah ^a   Banuelos, Stephanie ^a,b   Perrella, Laura ^a   Hardy, Brittany ^a,c  

^a SAM HOUSTON STATE UNIVERSITY   (United States)

^b Texas Department of Public Safety Crime Laboratory   (United States)

^c Dallas County Institute of Forensic Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 DIMETHOXY 4 BROMOPHENETHYLAMINE; 2,5 DIMETHOXY 4 ETHYLTHIOPHENETHYLAMINE; 2,5 DIMETHOXY 4 IODOPHENETHYLAMINE; 2,5 DIMETHOXY 4 METHYLAMPHETAMINE; 2,5 DIMETHOXY 4 PROPYLTHIOPHENETHYLAMINE; 2,5 DIMETHOXYPHENETHYLAMINE; 4 ETHYL 2,5 DIMETHOXYAMPHETAMINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 4 METHYLTHIOAMPHETAMINE; BROLAMFETAMINE; PHENETHYLAMINE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CHEMICAL STRUCTURE; FORENSIC TOXICOLOGY; HUMAN; MASS FRAGMENTOGRAPHY; SOLID PHASE EXTRACTION; URINALYSIS; URINE LEVEL;

EID: 80052632252     PISSN: 01464760     EISSN: 19452403     Source Type: Journal    
DOI: 10.1093/anatox/35.7.459     Document Type: Article

References (67)

1. A. Shulgin and A. Shulgin. Phenethylamines I Have Known and Loved (PiHKAL): A Chemical Love Story. Transform Press, Berkeley, CA, 1991.
2. R. Haroz and M.I. Greenberg. New drugs of abuse in North America. Clin. Lab. Med. 26: 147-164 (2006).
3. The Vaults of Erowid. Psychoactive Vaults. www.erowid.org (accessed April 2010).
4. Drug Enforcement Administration. List of Scheduling Actions. http://www.deadiversion.usdoj.gov (accessed January 2011).
5. V. Habrdova, F.T. Peters, D.S. Theobald, and H.H. Maurer. Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry. J. Mass Spectrom. 40: 785-795 (2005).
6. National Drug Intelligence Center: U.S. Department of Justice. Information Bulletin. 2C-B (Nexus) reappears on the club drug scene. May 2001.
7. S.P. Elliott. Fatal poisoning with a new phenethylamine: 4-methylthioamphetamine (4-MTA). J. Anal. Toxicol. 24: 85-89 (2000).
8. E.A. De Letter, V.A. Coopman, J.A. Cordonnier, and M.H. Piette. One fatal and seven non-fatal cases of 4-methylthioamphetamine (4-MTA) intoxication: clinico-pathological findings. Int. J. Legal Med. 114: 352-356 (2001).
9. T. Dacaestecker, E. De Letter, K. Clauwert, M. Bouche, W. Lambert, J. Van Bocxlaer, M. Piette, E. Van den Eeckhout, C. Van Peteghem, and A. De Leenheer. Fatal 4-MTA intoxication: development of a liquid chromatographic-tandem mass spectrometric assay for multiple matrices. J. Anal. Toxicol. 25: 705-710 (2001).
10. B. Curtis, P. Kemp, L. Harty, C. Choi, and D. Christensen. Postmortem identification and quantitation of 2,5-dimethoxy-4-npropylthiophenethylamine using GC-MSD and GC-NPD. J. Anal. Toxicol. 27: 493-498 (2003).
11. European Monitoring Centre for Drugs and Drug Addiction. Report on the risk assessment of 2C-I, 2C-T-2, and 2C-T-7 in the framework of the joint action on new synthetic drugs, 2004.
12. M. Balíková. Non-fatal and fatal DOB (2,5-dimethoxy-4-bromoamphetamine) overdose. Forensic Sci. Int. 153: 85-91 (2005).
13. U.S. Drug Enforcement Administration. 4-Bromo-2,5-dimethoxyphenethylamine (2C-B, "Nexus") tablets seized in Tennessee. Microgram Bull. 42(11): 84 (2009).
14. U.S. Drug Enforcement Administration. Blotter acid mimic (actually containing 4-bromo-2,5-dimethoxy-amphetamine (DOB) and 4-chloro-2,5-dimethoxy-amphetamine (DOC)) in Pratt County, Kansas. Microgram Bull. 42(4): 36 (2009).
15. U.S. Drug Enforcement Administration. Blotter acid mimic (actually containing a mixture of 4-chloro-2,5-dimethoxyamphetamine and 4-bromo-2,5-dimethoxyamphetamine) in Warner Robins, Georgia. Microgram Bull. 42(3): 25 (2009).
16. U.S. Drug Enforcement Administration. Ecstasy mimic tablets (actually containing 4-iodo-2,5-dimethoxyphenethylamine hydrochloride (2C-I) in Sherwood, Arkansas. Microgram Bull. 41(8): 72 (2008).
17. U.S. Drug Enforcement Administration. Solutions of 4-ethyl-2,5-dimethoxyphenethylamine (2C-E) in dropper bottles in Kentucky. Microgram Bull. 41(7): 60 (2008).
18. U.S. Drug Enforcement Administration. LSD blotter acid mimics (actually containing 4-iodo-2,5-dimethoxyamphetamine (DOI) and 4-chloro-2,5-dimethoxyamphetamine (DOC)) in Lantana, Florida. Microgram Bull. 41(6): 53 (2008).
19. U.S. Drug Enforcement Administration. Poly-drug seizure of hallucinogens in Upper Darby Township, Pennsylvania. Microgram Bull. 41(3): 27 (2008).
20. U.S. Drug Enforcement Administration. LSD blotter acid mimic (actually containing a mixture of 4-chloro-2,5-dimethoxyamphetamine (DOC) and 4-iodo-2,5-dimethoxyamphetamine (DOI)) in Paducah, Kentucky. Microgram Bull. 41(3): 28 (2008).
21. U.S. Drug Enforcement Administration. LSD blotter acid mimics containing 4-chloro-2,5-dimethoxy-amphetamine (DOC) in Concord, California. Microgram Bull. 40(12): 110 (2007).
22. U.S. Drug Enforcement Administration. Recent, unusual drug submissions in New Zealand. Microgram Bull. 40(12): 110 (2007).
23. U.S. Drug Enforcement Administration. 4-Chloro-2,5-dimethoxyamphetamine (DOC) in Santa Fe, New Mexico. Microgram Bull. 40(10): 93 (2007).
24. U.S. Drug Enforcement Administration. 4-Iodo-2,5-dimethoxyamphetamine (DOI) in Madison, Wisconsin. Microgram Bull. 40(9): 89 (2007).
25. U.S. Drug Enforcement Administration. Capsules containing 2,5-dimethoxy-4-ethylphenethylamine (2C-E) in Tulsa, Oklahoma. Microgram Bull. 40(4): 38 (2007).
26. U.S. Drug Enforcement Administration. Aqueous solutions of 4-chloro-2,5-dimethoxyamphetamine (DOC) in Tampa, Florida. Microgram Bull. 40(4): 42 (2007).
27. U.S. Drug Enforcement Administration. Large polydrug seizure near Salem, Oregon. Microgram Bull. 40(2): 20-22 (2007).
28. U.S. Drug Enforcement Administration. Blotter acid mimics (containing 4-bromo-2,5-dimethoxyamphetamine (DOB)) in Concord, California. Microgram Bull. 40(2): 24 (2007).
29. U.S. Drug Enforcement Administration. LSD blotter acid mimics (containing 4-bromo-2,5-dimethoxy-amphetamine (DOB)) in Ames, Iowa. Microgram Bull. 39(12): 145 (2006).
30. U.S. Drug Enforcement Administration. Blotter acid mimics (containing 4-bromo-2,5-dimethoxy-amphetamine (DOB)) in Concord, California. Microgram Bull. 39(11): 136 (2006).
31. U.S. Drug Enforcement Administration. 4-Chloro-2,5-dimethoxyamphetamine (DOC) and 4-iodo-2,5-dimethoxyamphetamine (DOI) in Berkley, Michigan. Microgram Bull. 39(11): 137 (2006).
32. U.S. Drug Enforcement Administration. Ecstasy mimic tablets (containing meta-chlorophenyl-piperazine (MCPP)), and capsules containing 2,5-dimethoxy-4-iodophenethylamine (2C-I), in Iowa. Microgram Bull. 39(9): 112 (2006).
33. U.S. Drug Enforcement Administration. LSD blotter acid mimics (containing 2,5-dimethoxy-4-chloro-amphetamine (DOC)) in Boca Raton, Florida. Microgram Bull. 39(6): 72 (2006).
34. U.S. Drug Enforcement Administration. LSD blotter acid mimics (containing 4-iodo-2,5-dimethoxy-amphetamine (DOI)) in Orlando andWinter Springs, Florida. Microgram Bull. 39(5): 55 (2006).
35. U.S. Drug Enforcement Administration. 2C-I capsules in Miami Beach, Florida. Microgram Bull. 39(1): 3-4 (2006).
36. U.S. Drug Enforcement Administration. LSD blotter acid mimic containing 4-chloro-2,5-dimethoxy-phenethylamine (2C-C) in Washington County, Oregon. Microgram Bull. 38(11): 163 (2005).
37. U.S. Drug Enforcement Administration. LSD blotter acid mimic containing 4-bromo-2,5-dimethoxy-amphetamine (DOB) seized near Burns, Oregon. Microgram Bull. 38(10): 147-148 (2005).
38. U.S. Drug Enforcement Administration. 2,5-Dimethoxy-4-ethylphenethylamine (2C-E) capsules in Bettendorf, Iowa. Microgram Bull. 38(4): 59 (2005).
39. U.S. Drug Enforcement Administration. 2C-B laboratory seized in Tioga County, New York. Microgram Bull. 37(12): 208-209 (2004).
40. U.S. Drug Enforcement Administration. 2,5-dimethoxy-4-ethylphenethylamine (2C-E) encountered in Ft. Pierce, Florida and Royal Oak, Michigan. Microgram Bull. 37(11): 193 (2004).
41. U.S. Drug Enforcement Administration. Additional information on the MDMA laboratory in Marion, South Dakota. Microgram Bull. 37(7): 130 (2004).
42. U.S. Drug Enforcement Administration. Dipropyltryptamine and 2C-I in Portland, Oregon. Microgram Bull. 37(6): 113-114 (2004).
43. U.S. Drug Enforcement Administration. 2C-I tablets in the Balearic Islands (Spain). Microgram Bull. 37(3): 48-49 (2004).
44. U.S. Drug Enforcement Administration. Unusual polydrug seizure in Ellsworth, Kansas. Microgram Bull. 37(1): 8 (2004).
45. U.S. Drug Enforcement Administration. Psilocybe mushrooms, dimethyltryptamine, MDMA and 4-bromo-2,5-dimethoxyphenethylamine (2C-B, Nexus) seized in Albany, Oregon. Microgram Bull. 43(3): 8 (2010).
46. U.S. Drug Enforcement Administration. Ecstasy mimic tablets actually containing 4-bromo-2,5-dimethoxyphenethylamine (2CB, Nexus) seized in Houston, Texas. Microgram Bull. 43(7): 69 (2010).
47. A.J. Poortman and E. Lock. Analytical profile of 4-methylthioamphetamine (4-MTA), a new street drug. Forensic Sci. Int. 100: 221-233 (1999).
48. T. Kanamori, H. Inoue, Y. Iwata, Y. Ohmae, and T. Kishi. In vivo metabolism of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in the rat: identification of urinary metabolites. J. Anal. Toxicol. 26: 61-66 (2002).
49. T. Kanamori, K. Tsujikawa,Y. Ohmae,Y. Iwata, H. Inoue,Y. Inouye, and T. Kishi. Excretory profile of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rat. J. Health Sci. 49: 166-169 (2003).
50. L.-C. Lin, J.-T. Liu, S.-H. Chou, and C.-H. Lin. Identification of 2,5-dimethoxy-4-ethylthiophenethylamine and its metabolites in the urine of rats by gas chromatography-mass spectrometry. J. Chromatogr. B 798: 241-247 (2003).
51. M. Soares, M. Carvalho, H. Carmo, F. Remiao, F. Carvalho, and M. Bastos. Simultaneous determination of amphetamine derivatives in human urine after SPE extraction and HPLC-UV analysis. Biomed. Chromatogr. 18: 125-131 (2004).
52. S.P.Vorce and J.H. Sklerov. A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-ESI-MS and HPLC-electrospray-MS. J. Anal. Toxicol. 28: 407-410 (2004).
53. G. Boatto, M. Nieddu, A. Carta, A. Pau, M. Palomba, B. Asproni, and R. Cerri. Determination of amphetamine-derived designer drugs in human urine by SPE extraction and capillary electrophoresis with mass spectrometry detection. J. Chromatogr. B 814: 93-98 (2005).
54. A.H. Ewald, F.T. Peters, M. Weise, and H.H. Maurer. Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography-mass spectrometry. J. Chromatogr. B 824: 123-131 (2005).
55. D.S. Theobald, S. Fehn, and H.H. Maurer. New designer drug, 2,5-dimethoxy-4-propylthio-β-phenethylamine (2C-T-7): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry. J. Mass Spectrom. 40: 105-116 (2005).
56. D.S. Theobald, R.F. Staack, M. Puetz, and H.H. Maurer. New designer drug 2,5-dimethoxy-4-ethylthio-β-phenethylamine (2C-T-2): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry. J.Mass Spectrom. 40: 1157-1172 (2005).
57. A.H. Ewald, G. Fritschi, W-R. Bork, and H.H. Maurer. Designer drugs 2,5-dimethoxy-4-bromo-amphetamine (DOB) and 2,5-dimethoxy-4-bromo-methamphetamine (MDOB): studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques. J. Mass Spectrom. 41: 487-498 (2006).
58. T. Ishida, K. Kudo, H. Inoue, A. Tsuji, T. Kojima, and N. Ikeda. Rapid screening for and simultaneous semiquantitative analysis of thirty abused drugs in human urine samples using gas chromatography-mass spectrometry. J. Anal. Toxicol. 30: 468-477 (2006).
59. D.S. Theobald, M. Putz, E. Schneider, and H.H. Maurer. New designer drug 4-iodo-2,5-dimethoxy-β-phenethylamine (2C-I): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric and capillary electrophoretic/mass spectrometric techniques. J.Mass Spectrom. 41:872-886 (2006).
60. C.-C. Tsai, J.-T. Liu, Y.-R. Shu, P.-H. Chan, and C.-H. Lin. Optimization of the separation and on-line sample concentration of phenethylamine designer drugs with capillary electrophoresis-fluorescence detection. J. Chromatogr. A 1101: 319-323 (2006).
61. J.L. da Costa, A.Y. Wang, G.A. Micke, A.O. Maldaner, R.L. Romano, H.A. Martins-Junior, O.N. Neto, and M.F. Tavares. Chemical identification of 2,5-dimethoxy-4-bromoamphetamine (DOB). Forensic Sci. Int. 173: 130-136 (2007).
62. A.H. Ewald, G. Fritschi, and H.H. Maurer. Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxyamphetamine (DOI) in rat urine using gas chromatography-mass spectrometry. J. Chromatogr. B 857: 170-174 (2007).
63. M. Nieddu, G. Boatto, and G. Dessi. Determination of 4-alkyl 2,5 dimethoxy-amphetamine derivatives by capillary electrophoresis with mass spectrometry detection from urine samples. J. Chromatogr. B 852: 578-581 (2007).
64. D.S. Theobald, G. Fritschi, and H.H. Maurer. Studies on the toxicological detection of the designer drug 4-bromo-2,5-dimethoxy-β-phenethylamine (2C-B) in rat urine using gas chromatography-mass spectrometry. J. Chromatogr. B 846: 374-377 (2007).
65. A.H. Ewald, M. Puetz, and H.H. Maurer. Designer drug 2,5-dimethoxy-4-methyl-amphetamine (DOM, STP): involvement of the cytochrome P450 isoenzymes in formation of its main metabolite and detection of the latter in rat urine as proof of a drug intake using gas chromatography-mass spectrometry. J. Chromatogr. B 862: 252-256 (2008).
66. M. Rohanová, T. Páleníček, and M. Balíková. Disposition of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) and its metabolite 4-bromo-2-hydroxy-5-methoxyphenethylamine in rats after subcutaneous administration. Toxicol. Lett. 178: 29-36 (2008).
67. A.Wohlfarth,W.Weinmann, and S. Dresen. LC.MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum. Anal. Bioanal. Chem. 396: 2403-2414 (2010).